P.A.W. Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

P.A.W. Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,000	Closed	-$951K	–	69
2018 Q2	$830K	Hold	9,000	–	–	0.84%	35
2018 Q1	$898K	Sell	9,000 -3,000	-25%	-$323K	1.08%	29
2017 Q4	$1.13M	Buy	12,000 +2,000	+20%	+$189K	1.42%	26
2017 Q3	$1.02M	Sell	10,000 -2,500	-20%	-$218K	1.07%	39
2017 Q2	$957K	Sell	12,500 -7,500	-38%	-$631K	0.96%	45
2017 Q1	$1.72M	Sell	20,000 -5,000	-20%	-$360K	1.74%	15
2016 Q4	$1.6M	Buy	25,000 +13,000	+108%	+$800K	1.81%	23
2016 Q3	$776K	Sell	12,000 -8,000	-40%	-$451K	0.83%	35
2016 Q2	$1.11M	Buy	+20,000	New	+$1.01M	1.27%	29

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

P.A.W. Capital's LKFT Position: Q3 2018 in Review

P.A.W. Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2018, closing a stake of 9,000 shares — an estimated $951K sold.

P.A.W. Capital first reported a position in LKFT in Q2 2016 and held it in 9 quarters. The position peaked at $1.72M in Q1 2017. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2018.

P.A.W. Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2018 after selling out during the quarter.
P.A.W. Capital sold 9,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2018, an estimated $951K.
P.A.W. Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2016 and held it in 9 quarters.
P.A.W. Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.72M in Q1 2017.
92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2018.

Based on P.A.W. Capital's 13F filing for Q3 2018, filed 24 Oct 2018.